Cargando…

Impact of point A asymmetry on local control and survival for low dose-rate (LDR) brachytherapy in cervical cancer

PURPOSE: To evaluate whether Point A asymmetry in low dose-rate (LDR) brachytherapy is associated with local control (LC), disease-free survival (DFS) and/or overall survival (OS). MATERIAL AND METHODS: A retrospective analysis of disease control and survival outcomes was conducted for patients who...

Descripción completa

Detalles Bibliográficos
Autores principales:	Opfermann, Krisha J, Wahlquist, Amy, Watkins, John, Kohler, Matthew, Jenrette, Joseph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2012
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551371/ https://www.ncbi.nlm.nih.gov/pubmed/23346133 http://dx.doi.org/10.5114/jcb.2012.27945

Ejemplares similares

Langzeitauswertung der Low-dose-rate(LDR)-Brachytherapie des lokal begrenzten Prostatakarzinoms
por: Carl, N., et al.
Publicado: (2023)

The use of nomograms in LDR-HDR prostate brachytherapy
por: Pujades, Ma Carmen, et al.
Publicado: (2011)

Low‐Dose‐Rate Prostate Brachytherapy (LDR‐PB) adopts postsurgical PSA value for definition of cure
por: Uribe, Jennifer, et al.
Publicado: (2020)

A Brief Review of Low-Dose Rate (LDR) and High-Dose Rate (HDR) Brachytherapy Boost for High-Risk Prostate
por: Fischer-Valuck, Benjamin W., et al.
Publicado: (2019)

Is there any place for LDR brachytherapy for head and neck carcinomas in HDR era?
por: Fijuth, Jacek
Publicado: (2009)

Ten‐step method of high‐dose LDR (125)I brachytherapy for intermediate‐risk prostate cancer
por: Okamoto, Keisei
Publicado: (2021)

Evaluation of the effect of prostate volume change on tumor control probability in LDR brachytherapy
por: Knaup, Courtney, et al.
Publicado: (2011)

HDR and LDR Brachytherapy in the Treatment of Lip Cancer: the Experience of the Catalan Institute of Oncology
por: Ayerra, Arrate Querejeta, et al.
Publicado: (2010)

Minimal percentage of dose received by 90% of the urethra (%UD90) is the most significant predictor of PSA bounce in patients who underwent low-dose-rate brachytherapy (LDR-brachytherapy) for prostate cancer
por: Tanaka, Nobumichi, et al.
Publicado: (2012)

Time to PSA rise differentiates the PSA bounce after HDR and LDR brachytherapy of prostate cancer
por: Burchardt, Wojciech, et al.
Publicado: (2018)

The CivaSheet: The new frontier of intraoperative radiation therapy or a pricier alternative to LDR brachytherapy?
por: Seneviratne, Danushka, et al.
Publicado: (2017)

Determining Combined Modality Dosimetric Constraints by Integration of IMRT and LDR Prostate Brachytherapy Dosimetry and Correlation with Toxicity
por: Riegel, Adam C., et al.
Publicado: (2022)

CTRL: Closed-Loop Transcription to an LDR via Minimaxing Rate Reduction
por: Dai, Xili, et al.
Publicado: (2022)

Concomitant cervical and transperineal parametrial high-dose-rate brachytherapy boost for locally advanced cervical cancer
por: Bailleux, Caroline, et al.
Publicado: (2016)

Developing a Treatment Planning Software Based on TG-43U1 Formalism for Cs-137 LDR Brachytherapy
por: Sina, Sedigheh, et al.
Publicado: (2013)

Automated calculation of point A coordinates for CT-based high-dose-rate brachytherapy of cervical cancer
por: Kang, Hyejoo, et al.
Publicado: (2017)

Inter-observer and intra-observer variability in reporting vaginal dose points for cervical cancer in high-dose-rate brachytherapy
por: Carrasco, Nuria, et al.
Publicado: (2020)

Study of positional dependence of dose to bladder, pelvic wall and rectal points in High-Dose-Rate Brachytherapy in cervical cancer patients
por: Talluri, Anil Kumar, et al.
Publicado: (2013)

Biological effective doses in the intracavitary high dose rate brachytherapy of cervical cancer
por: Sharma, B. Arunkumar, et al.
Publicado: (2011)

Robotic Salvage Seminal Vesiculectomy for radio-recurrent prostate cancer post LDR brachytherapy following multiple negative trans-perineal biopsies
por: Katelaris, Dr Athos, et al.
Publicado: (2022)

Impact of pre-brachytherapy magnetic resonance imaging on dose-volume histogram of locally advanced cervical cancer patients treated with radiotherapy including high-dose-rate brachytherapy
por: Murofushi, Keiko Nemoto, et al.
Publicado: (2021)

Current situation of high-dose-rate brachytherapy for cervical cancer in Brazil
por: da Silva, Rogério Matias Vidal, et al.
Publicado: (2014)

Low dose rate brachytherapy using a tandem for cervical cancer
por: Javier, Aguirre Mendez, et al.
Publicado: (2010)

Combined Interstitial and Intracavitary High-Dose Rate Brachytherapy of Cervical Cancer
por: Itami, Jun, et al.
Publicado: (2022)

Three-dimensional dosimetric considerations from different point A definitions in cervical cancer low-dose-rate brachytherapy
por: Zhang, Miao, et al.
Publicado: (2013)

Biological equivalence between LDR and PDR in cervical cancer: multifactor analysis using the linear-quadratic model
por: Couto, José Guilherme, et al.
Publicado: (2011)

Dose to pelvic lymph nodes in locally advanced cervical cancer during high-dose-rate brachytherapy with tandem-ring applicators
por: Moghani, Mona Malekzadeh, et al.
Publicado: (2022)

Brachytherapy utilization rate and effect on survival in cervical cancer patients in Korea
por: Kim, Young Ae, et al.
Publicado: (2021)

Indian Brachytherapy Society Guidelines for radiotherapeutic management of cervical cancer with special emphasis on high-dose-rate brachytherapy
por: Mahantshetty, Umesh, et al.
Publicado: (2019)

Optical fibre based real-time measurements during an LDR prostate brachytherapy implant simulation: using a 3D printed anthropomorphic phantom
por: Woulfe, P., et al.
Publicado: (2021)

Dosimetric impact of point A definition on high-dose-rate brachytherapy for cervical cancer: evaluations on conventional point A and MRI-guided, conformal plans
por: Anderson, James, et al.
Publicado: (2012)

Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2020)

A Phase 2 Randomized Pilot Study Comparing High-Dose-Rate Brachytherapy and Low-Dose-Rate Brachytherapy as Monotherapy in Localized Prostate Cancer
por: Hathout, Lara, et al.
Publicado: (2019)

Assessment of the anatomical position of point B and the relationship between point B dose and the dose delivered to pelvic lymph nodes in CT-based high-dose-rate brachytherapy for uterine cervical cancer
por: Matsukawa, Hideaki, et al.
Publicado: (2019)

Concurrent Chemo- Radiobrachytherapy with Cisplatin and Medium Dose Rate Intra- Cavitary Brachytherapy for Locally Advanced Uterine Cervical Cancer
por: Aghili, Mahdi, et al.
Publicado: (2018)

Comparative dosimetrical analysis of intensity-modulated arc therapy, CyberKnife therapy and image-guided interstitial HDR and LDR brachytherapy of low risk prostate cancer
por: Fröhlich, Georgina, et al.
Publicado: (2021)

Response to ‘Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer’
por: Slevin, Finbar, et al.
Publicado: (2020)

High-dose-rate brachytherapy with external beam radiotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2021)

Revision of the dosimetric parameters of the CSM11 LDR Cs-137 source
por: Otal, Antonio, et al.
Publicado: (2011)

Site-Specific Labeling of Endogenous Proteins Using CoLDR Chemistry
por: Reddi, Rambabu N., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fqll6l0fdgj468a9l52tg0ficg